Calculation of the volume of the normal and the hypertrophic breast.

Aesthetic Plast Surg

The Service of Plastic Surgery, The University Hospital San Vicente De Paul, Medellin, Colombia.

Published: December 1980

Using the same system as has been previously described for the Natural Pattern, we have produced a mold with Scotch tape, Ref. 202, that precisely reproduces the size and shape of normal and hypertrophic breasts. Using this mold technique, we studied the specific weight of mammary tissues, and found an average volume of 360 to 390 cc in normal women. This volume figure, varying according to height and weight of the patient, is subtracted from that of a hypertrophic gland to determine how much to resect in a breast reduction procedure. A postoperative mold is made that can be used as a control should the patient return due to recurrence of the hypertrophy.

Download full-text PDF

Source
http://dx.doi.org/10.1007/BF01575223DOI Listing

Publication Analysis

Top Keywords

normal hypertrophic
8
calculation volume
4
volume normal
4
hypertrophic breast
4
breast system
4
system described
4
described natural
4
natural pattern
4
pattern produced
4
produced mold
4

Similar Publications

Astragali Radix-Notoginseng Radix et Rhizoma medicine pair prevents cardiac remodeling by improving mitochondrial dynamic balance.

Chin J Nat Med

January 2025

Jiangsu Key Laboratory of TCM Evaluation and Translational Research, Research Center for Traceability and Standardization of TCMs, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, China. Electronic address:

Astragali Radix (AR) and Notoginseng Radix et Rhizoma (NR) are frequently employed in cardiovascular disease treatment. However, the efficacy of the AR-NR medicine pair (AN) in improving cardiac remodeling and its underlying mechanism remains unclear. This study aimed to evaluate AN's cardioprotective effect and potential mechanism on cardiac remodeling using transverse aortic constriction (TAC) in mice and angiotensin II (Ang II)-induced neonatal rat cardiomyocytes (NRCMs) and fibroblasts in vitro.

View Article and Find Full Text PDF

Targeting Chondrocyte Hypertrophy as Strategies for the Treatment of Osteoarthritis.

Bioengineering (Basel)

January 2025

Institute of Tissue Regeneration Engineering (ITREN), Dankook University, Cheonan 31116, Republic of Korea.

Osteoarthritis (OA) is a common joint disease characterized by pain and functional impairment, which severely impacts the quality of life of middle-aged and elderly individuals. During normal bone development, chondrocyte hypertrophy is a natural physiological process. However, in the progression of OA, chondrocyte hypertrophy becomes one of its key pathological features.

View Article and Find Full Text PDF

Background: Exploring the potential of as a diagnostic biomarker in prostate cancer.

Methods: Expression of the lncRNA was analyzed between normal and tumor samples in the GDC TCGA PRAD (Genomic Data Commons: The Cancer Genome Atlas Prostate Adenocarcinoma Collection) dataset. Disease progression-related clinicopathological parameters such as serum PSA level (ng/ml) and Gleason score were associated with the expression of using the same GDC TCGA PRAD dataset.

View Article and Find Full Text PDF

High-sensitive cardiac troponin T and NT-proBNP are associated with the left ventricular apical thickness in apical hypertrophic cardiomyopathy.

Eur J Med Res

January 2025

Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, Shanghai, China.

Background: Apical hypertrophic cardiomyopathy (AHCM) is a subtype of hypertrophic cardiomyopathy (HCM). The expression level of high-sensitive cardiac troponin T (hs-cTNT) and N-terminal pro-BNP (NT-proBNP) in AHCM patients, and these relationships between echocardiography parameters were still unclear.

Methods: We retrospectively screened AHCM patients between January 2019 and December 2021 in Zhongshan Hospital Fudan University.

View Article and Find Full Text PDF

Structural and Functional Characterization of the Aorta in Hypertrophic Obstructive Cardiomyopathy.

Circ Heart Fail

January 2025

Aswan Heart Center, Magdi Yacoub Heart Foundation, Egypt (A.M.I., M.R., A. Elsawy, M.H., S.H., W.E., A. Elaithy, A. Elguindy, A. Afifi, Y.A., M.Y.).

Background: Changes in the phenotype and genotype in hypertrophic cardiomyopathy (HCM) are thought to involve the myocardium as well as extracardiac tissues. Here, we describe the structural and functional changes in the ascending aorta of obstructive patients with HCM.

Methods: Changes in the aortic wall were studied in a cohort of 101 consecutive patients with HCM undergoing myectomy and 9 normal controls.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!